HMGB3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.386400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.141800E-01
Normal-vs-Stage2
9.122000E-01
Normal-vs-Stage3
9.325000E-01
Normal-vs-Stage4
7.700400E-01
Stage1-vs-Stage2
6.468000E-01
Stage1-vs-Stage3
6.367800E-01
Stage1-vs-Stage4
5.010200E-01
Stage2-vs-Stage3
8.226400E-01
Stage2-vs-Stage4
6.871200E-01
Stage3-vs-Stage4
8.417200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.029600E-01
Normal-vs-AfricanAmerican
7.640800E-01
Normal-vs-Asian
7.881800E-01
Caucasian-vs-AfricanAmerican
1.715580E-01
Caucasian-vs-Asian
4.136600E-01
AfricanAmerican-vs-Asian
9.807000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.827200E-01
Normal-vs-Female
7.234600E-01
Male-vs-Female
1.175790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.813000E-01
Normal-vs-Age(41-60Yrs)
6.370600E-01
Normal-vs-Age(61-80Yrs)
9.916600E-01
Normal-vs-Age(81-100Yrs)
9.756600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.163400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.035000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.124400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.367800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.985040E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.430200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.648800E-01
Normal-vs-Daily Drinker
6.659600E-01
Normal-vs-Weekly Drinker
7.753000E-01
Normal-vs-Occasional Drinker
8.373200E-01
Normal-vs-Social Drinker
6.772400E-01
Non Drinker-vs-Daily Drinker
3.436800E-01
Non Drinker-vs-Weekly Drinker
5.848600E-01
Non Drinker-vs-Occasional Drinker
8.198000E-01
Non Drinker-vs-Social Drinker
5.254600E-01
Daily Drinker-vs-Weekly Drinker
9.822800E-01
Daily Drinker-vs-Occasional Drinker
4.462400E-01
Daily Drinker-vs-Social Drinker
7.706200E-01
Weekly Drinker-vs-Occasional Drinker
6.608200E-01
Weekly Drinker-vs-Social Drinker
8.565200E-01
Occasional Drinker-vs-Social Drinker
6.209800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.037200E-01
Normal-vs-Grade 2
5.967600E-01
Normal-vs-Grade 3
6.203000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.249200E-01
Grade 1-vs-Grade 3
5.003200E-01
Grade 1-vs-Grade 4
6.037200E-01
Grade 2-vs-Grade 3
1.581990E-01
Grade 2-vs-Grade 4
5.967600E-01
Grade 3-vs-Grade 4
6.203000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.493400E-01
Normal-vs-NonDiabetic
7.629200E-01
Diabetic-vs-NonDiabetic
1.693390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.588000E-01
Normal-vs-NoPancreatitis
8.452600E-01
Pancreatitis-vs-NoPancreatitis
4.502000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.065400E-01
Normal-vs-N1
9.326400E-01
N0-vs-N1
5.769600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.379000E-01
Normal-vs-TP53-NonMutant
8.588200E-01
TP53-Mutant-vs-TP53-NonMutant
3.100400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
